NEW YORK (GenomeWeb News) – Victoria, BC-based GenoLogics has raised $5 million in a private round of financing with venture capital investors.

The bioinformatics firm said that proceeds would be used to fund its ongoing expansion plans and to accelerate development and global deployment of an end-to-end informatics solution for organizations pursuing translational research initiatives.

Seattle-based OVP Venture Partners led the round of financing with additional investment from Growth Works and Yaletown Venture Partners of Vancouver.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.

May
28
Sponsored by
PerkinElmer

This online seminar will demonstrate how RNA-seq analysis in a model organism can provide insights into human disease.